Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Total Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H has a market cap or net worth of HK$9.48B. The enterprise value is HK$5.38B.
Market CapHK$9.48B
Enterprise ValueHK$5.38B
Share Statistics
Shanghai Haohai Biological Technology Co., Ltd. Class H has 35,929,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,929,040
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Haohai Biological Technology Co., Ltd. Class H’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 3.96%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)3.96%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee1.11M
Profits Per Employee113.41K
Employee Count2,156
Asset Turnover0.36
Inventory Turnover1.60
Valuation Ratios
The current PE Ratio of Shanghai Haohai Biological Technology Co., Ltd. Class H is 20.8. Shanghai Haohai Biological Technology Co., Ltd. Class H’s PEG ratio is -0.50.
PE Ratio20.8
PS Ratio2.13
PB Ratio0.94
Price to Fair Value0.94
Price to FCF11.41
Price to Operating Cash Flow14.08
PEG Ratio-0.50
Income Statement
In the last 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H had revenue of 2.40B and earned 244.51M in profits. Earnings per share was 1.05.
Revenue2.40B
Gross Profit1.56B
Operating Income278.96M
Pretax Income233.33M
Net Income244.51M
EBITDA480.36M
Earnings Per Share (EPS)1.05
Cash Flow
In the last 12 months, operating cash flow was 640.11M and capital expenditures -187.77M, giving a free cash flow of 452.36M billion.
Operating Cash Flow640.11M
Free Cash Flow452.36M
Free Cash Flow per Share12.59
Dividends & Yields
Shanghai Haohai Biological Technology Co., Ltd. Class H pays an annual dividend of HK$0.438, resulting in a dividend yield of 4.28%
Dividend Per ShareHK$0.438
Dividend Yield4.28%
Payout Ratio48.40%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-6.12%
50-Day Moving Average24.67
200-Day Moving Average26.35
Relative Strength Index (RSI)38.37
Average Volume (3m)211.55K
Important Dates
Shanghai Haohai Biological Technology Co., Ltd. Class H upcoming earnings date is Apr 25, 2026, TBA (Confirmed).
Last Earnings DateMar 20, 2026
Next Earnings DateApr 25, 2026
Ex-Dividend Date―
Financial Position
Shanghai Haohai Biological Technology Co., Ltd. Class H as a current ratio of 3.79, with Debt / Equity ratio of 7.35%
Current Ratio3.79
Quick Ratio3.21
Debt to Market Cap0.07
Net Debt to EBITDA-4.27
Interest Coverage Ratio15.17
Taxes
In the past 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H has paid 30.12M in taxes.
Income Tax30.12M
Effective Tax Rate0.13
Enterprise Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H EV to EBITDA ratio is 6.34, with an EV/FCF ratio of 6.82.
EV to Sales1.27
EV to EBITDA6.34
EV to Free Cash Flow6.82
EV to Operating Cash Flow4.84
Balance Sheet
Shanghai Haohai Biological Technology Co., Ltd. Class H has HK$2.52B in cash and marketable securities with HK$398.67M in debt, giving a net cash position of HK$2.13B billion.
Cash & Marketable SecuritiesHK$2.52B
Total DebtHK$398.67M
Net CashHK$2.13B
Net Cash Per ShareHK$59.15
Tangible Book Value Per ShareHK$21.22
Margins
Gross margin is 100.00%, with operating margin of 11.64%, and net profit margin of 10.20%.
Gross Margin100.00%
Operating Margin11.64%
Pretax Margin9.74%
Net Profit Margin10.20%
EBITDA Margin20.04%
EBIT Margin11.64%
Analyst Forecast
The average price target for Shanghai Haohai Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-8.49%
EPS Growth Forecast-9.46%